The NPCA team is pleased to announce the official launch of a Quality Improvement (QI) intervention in January 2026. The primary goal is to ensure men with hormone-sensitive metastatic prostate cancer are being treated with treatment intensification therapy where appropriate.
The intervention will be in three stages:
Outlier Process
Identify and provide feedback to potential negative outliers, addressing underlying issues, whether related to data submissions or clinical care.
Educational Webinars
- Evidence-based benefits of utilising treatment intensification
In collaboration with BURST, the NPCA hosted a webinar on “The use of systemic anti-cancer treatment in metastatic prostate cancer”
2. Optimal data collection and processing strategies
Date and Time: Thursday, 19 March 2026, 9-10 am
Location: Online (Teams Townhall)
Quarterly Data Dashboard
Results will be added to the NPCA Data Dashboard, updated quarterly, with repeated assessments to track progress over time.
NPCA QI Intervention Poster Understanding SACT Data Flow